Clinical Trials in Gwangju, South Korea
Locations / Gwangju, South Korea
Delta Trials catalogs 850 clinical trials conducted in Gwangju, South Korea, making it a notable site of clinical research activity. These trials spanning 614 distinct medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 88 trials in this location were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations in Gwangju evolve over time.
850
Total Trials
614
Conditions
88
Terminated since 2020
Browse by condition (614 total)
- Coronary artery disease 56 trialsAll Coronary artery disease trials
- Rheumatoid arthritis 31 trialsAll Rheumatoid arthritis trials
- Schizophrenia 27 trialsAll Schizophrenia trials
- Acute coronary syndrome 24 trialsAll Acute coronary syndrome trials
- Asthma 20 trialsAll Asthma trials
- Atrial fibrillation 18 trialsAll Atrial fibrillation trials
- Hypertension 18 trialsAll Hypertension trials
- Heart failure 15 trialsAll Heart failure trials
- Type 2 diabetes mellitus 13 trialsAll Type 2 diabetes mellitus trials
- Diabetes mellitus, type 2 12 trialsAll Diabetes mellitus, type 2 trials
- Arthritis, rheumatoid 11 trialsAll Arthritis, rheumatoid trials
- Stroke 11 trialsAll Stroke trials
- Psoriasis 10 trialsAll Psoriasis trials
- Systemic lupus erythematosus 10 trialsAll Systemic lupus erythematosus trials
- Ankylosing spondylitis 9 trialsAll Ankylosing spondylitis trials
- Acute myocardial infarction 9 trialsAll Acute myocardial infarction trials
- Myocardial infarction 9 trialsAll Myocardial infarction trials
- Hypercholesterolemia 8 trialsAll Hypercholesterolemia trials
- Ischemic stroke 8 trialsAll Ischemic stroke trials
- Atopic dermatitis 7 trialsAll Atopic dermatitis trials